LEVORPHANOL TARTRATE (Roxane Laboratories, Inc)
Welcome to the PulseAid listing for the LEVORPHANOL TARTRATE drug offered from Roxane Laboratories, Inc. This Full Opioid Agonists [MoA],Opioid Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Roxane Laboratories, Inc |
NON-PROPRIETARY NAME: | LEVORPHANOL TARTRATE |
SUBSTANCE NAME: | LEVORPHANOL TARTRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2000-03-31 |
END MARKETING DATE: | 2017-12-16 |
LEVORPHANOL TARTRATE HUMAN PRESCRIPTION DRUG Details:
Item Description | LEVORPHANOL TARTRATE from Roxane Laboratories, Inc |
LABELER NAME: | Roxane Laboratories, Inc |
DEA SCHEDULE: | CII
|
ACTIVE STRENGTH: | 2(mg/1) |
START MARKETING DATE: | 2000-03-31 |
END MARKETING DATE: | 2017-12-16 |
PRODUCT ID: | 0054-0438_15628d27-e0fd-40dd-bbfa-54a5490c924f |
PRODUCT NDC: | 0054-0438 |
APPLICATION NUMBER: | ANDA074278 |
Other LEVORPHANOL TARTRATE Pharmaceutical Manufacturers / Labelers: